Genome-scale CRISPR screening for potential targets of ginsenoside compound K

Cell Death Dis. 2020 Jan 20;11(1):39. doi: 10.1038/s41419-020-2234-5.

Abstract

Ginsenosides exhibit a large variety of biological activities in maintaining physical health; however, the molecule underpinnings underlining these biological activities remain to be defined. Here, we took a cellular condition that compound K (CK) induces autophagic cell death in HeLa cells, and setup a high-throughput genetic screening using CRISPR technology. We have identified a number of CK-resistant and CK-sensitive genes, and further validated PMAIP1 as a CK-resistant gene and WASH1 as a CK-sensitive gene. Compound K treatment reduces the expression of WASH1, which further accelerates the autophagic cell death, highlighting WASH1 as an interesting downstream mediator of CK effects. Overall, our study offers an easy-to-adopt platform to study the functional mediators of ginsenosides, and provides a candidate list of genes that are potential targets of CK.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autophagy / drug effects
  • Clustered Regularly Interspaced Short Palindromic Repeats / genetics
  • Drug Evaluation, Preclinical*
  • Drug Resistance, Neoplasm / drug effects
  • Genome*
  • Ginsenosides / pharmacology*
  • HEK293 Cells
  • HeLa Cells
  • High-Throughput Screening Assays
  • Humans
  • Proto-Oncogene Proteins c-bcl-2 / metabolism

Substances

  • Ginsenosides
  • PMAIP1 protein, human
  • Proto-Oncogene Proteins c-bcl-2
  • ginsenoside M1